Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
54.00
-1.56 (-2.81%)
Nov 17, 2026, 3:04 PM CST

SHE:002653 Revenue

Haisco Pharmaceutical Group had revenue of 1.87B CNY in the quarter ending September 30, 2026, with 44.30% growth. This brings the company's total for the last twelve months to 6.06B, up 41.87% year-over-year. In the year 2025, Haisco Pharmaceutical Group had annual revenue of 4.39B with 17.91% growth. That makes Haisco Pharmaceutical Group the 8,062nd largest company in the world by revenue and 1,220th in China.

Revenue (ttm)
6.06B
Revenue Growth
+41.87%
P/S Ratio
9.97
Revenue / Employee
1.08M
Employees
5,597
Market Cap
59.90B

Revenue Chart

Revenue by Segment

  • Parent Company 4.40B 49.7%
  • Tibet Pharmaceuticals Merger 2.55B 28.8%
  • Liaoning Hisun 548.14M 6.2%
  • Tibet Haize 534.79M 6.0%
  • Sichuan Hisun Corporation Merger 530.58M 6.0%
  • Shenyang Hisun 287.23M 3.2%
Fiscal year ended Dec 31, 2025 See the full SHE:002653 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.39B666.44M17.91%
Dec 31, 20243.72B366.28M10.92%
Dec 31, 20233.36B339.78M11.27%
Jan 1, 20233.02B241.98M8.73%
Jan 1, 20222.77B-556.28M-16.71%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.